Specifically, the region with MYCN amplification had a high mitosis–karyorrhexis index and was less likely to have ultrabright telomere foci, characteristic of ALT, in ATRX-mutant neuroblastoma cells (Fig. 1f–h and Supplementary Fig. 1B–E). The gene discussed is MYCN; the disease is neuroblastoma.